Arvinas Employees Give Back During Company-wide Impact Day
Arvinas Inc ARVN
$9.09
▼ -0.11%
($-0.01)
Open
$9.12
Prev Close
$9.10
Day Range
$8.96 – $9.34
52W Range
$6.06 – $14.51
Market Cap
$586.50M
Beta
1.76
EPS (TTM)
$-3.26
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2018-09-27 |
| Shares Out. | 64,520,000 |
| Website | arvinas.com/ ↗ |
| Phone | 12035351456 |
Arvinas Inc is a publicly traded company under the ticker symbol ARVN on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
26 analysts (2026-05-01)
📰 Latest News for ARVN
These Analysts Increase Their Forecasts On Arvinas After Q1 Results
Barclays Maintains Overweight on Arvinas, Raises Price Target to $20
Aramark To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
BTIG Maintains Buy on Arvinas, Raises Price Target to $18
Arvinas, Inc. (ARVN) Q1 2026 Earnings Call Transcript
Transcript : Arvinas, Inc., Q1 2026 Earnings Call, May 12, 2026
Rigel Pharmaceuticals Inks Breast Cancer Drug Deal With Arvinas, Pfizer